Republican politician Ben Sasse shared sad news on social media Tuesday: He's expecting to die soon from pancreatic cancer. Sasse, who served in the United States Senate representing Nebraska from ...
Health Canada has approved a new treatment for adults with recurrent or metastatic nasopharyngeal carcinoma, a rare form of head and neck cancer, the company behind the treatment said in a statement ...
SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- At 15:00 Beijing Time (09:00 am Berlin Time) on October 20, the "Global Launch Event for Iza-bren (EGFR×HER3 Bispecific ADC) Nasopharyngeal Carcinoma ...
Breastfeeding has long been linked to a reduced risk of breast cancer, but how it has this effect isn’t entirely clear. Now, scientists have found that women who have breastfed have more specialised ...
The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma (NPC) in adults. No trade name was indicated for the drug. The first ...
In a phase 3 trial, toripalimab-based chemotherapy with radiotherapy without concurrent cisplatin achieved noninferior 3-year failure-free survival compared with standard therapy in patients with ...
This illustration outlines the multi-step process used to construct the NPC-RSS (Nasopharyngeal Carcinoma Radiotherapy Sensitivity Score), including data collection from local transcriptomic samples, ...
Colon cancer is one of the most preventable cancers in the United States, but each year it claims more than 50,000 lives – in part because early symptoms can be mild and easily missed. “Colon cancer ...
Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback